Major Oral Rinse
FDA Label NDC 55154-3574

18 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Major Oral Rinse (NDC 55154-3574). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, pharmacokinetics, indication, contraindications, warnings, precautions, pregnancy: teratogenic effects, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Other Safety Information

STORE at 20°C to 25°C (68°F to 77°F), 30°C (59°F to 86°F) [See USP controlled Room Temperature].

Rx Only.

KEEP OUT OF REACH OF CHILDREN.

Revised: February 2022

Distributed by:

MAJOR® PHARMACEUTICALS

Livonia, MI 48152

Distributed By:

Cardinal Health

Dublin, OH 43017

L57474560925

Package/Label Display Panel

NDC 55154-3574-5

CHLORHEXIDINE GLUCONATE

ORAL RINSE USP, 0.12%

0.12% / 15 mL

5 CUPS

0.12% Bag Label (451400e3 E507 C11a E063 6394a90a6991 00)

0.12% Bag Label (451400e3 E507 C11a E063 6394a90a6991 00)

* Please review the disclaimer below.